Google released the first artificial intelligence model in its Gemini 2.0 family Wednesday, known as Gemini 2.0 Flash.

Social media warnings, food insecurity, unsafe hospitals, "forever chemicals," underinsured put off care, AI, vaccines, and ...

With Flash model, Google also introduced a new research prototype, Project Mariner, from its DeepMind division ...

In the last three months, 19 analysts have published ratings on Vertex Pharmaceuticals VRTX, offering a diverse range of perspectives from bullish to bearish. The following table encapsulates ...

As a result, biotech stocks can be highly volatile. Here's why I think Vertex Pharmaceuticals (NASDAQ: VRTX) is the ultimate biotech stock to buy with $500 right now. Jefferies has upgraded Vertex ...

Shares in Vertex have soared after the company announced that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time. The company is a pioneer in ...

Vertex has appointed a new commercial head for ex-US activites, as the company aims to resolve its two-year row with UK health officials over the price of its cystic fibrosis drugs.

If you're one of the many people suffering from poor sleep, some have been seeking relief from weighted blankets. But do they ...

Vertex Pharma has said it will use a priority review voucher (PRV) to speed up the FDA review of its new once-daily triple therapy for cystic fibrosis, which has just hit all its objectives in a ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Elke Scholiers for The New York Times Supported by By Alex Travelli and Suhasini Raj Alex Travelli reported from New Delhi and Suhasini Raj from Kolkata, India. When Donald J. Trump started his ...